Skip to content
‹ Back to IndustriesHealthcare

DESIGN TRANSFER: A PROCESS NOT A SINGULAR EVENT

In the development process for medical devices, there comes a point when products transfer from design to production. Often this step doesn’t go as smoothly as it should and the project budget and schedule are adversely impacted. Companies may view design transfer as a one-time event, rather than an essential part of an ongoing process….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

In the development process for medical devices, there comes a point when products transfer from design to production. Often this step doesn’t go as smoothly as it should and the project budget and schedule are adversely impacted. Companies may view design transfer as a one-time event, rather than an essential part of an ongoing process.

During the product development process, the Research and Development (R&D) team is under a tight deadline. They may not have the necessary resources or take sufficient time to create proper documentation. Team members may need to make decisions quickly without fully considering how they could take proactive steps to ensure design transfer will go more smoothly. Subject matter experts on the team may only focus on critical design decisions required to make the product work, without regard for manufacturing. Let’s take a look at some ways to improve design transfer.

Look at Design Transfer as a Process Rather than a Single Event

Design transfer is an integral part of the product development process, from conception through final manufacture. Highly reliable, cost-efficient medical devices require proper design transfer, and that starts with Design for Manufacturability (DFM) and Design for Manufacturing and Assembly (DFMA). In DFM and DFMA the focus is not only on the design itself, but also on the assembly method, ensuring manufacturing readiness for building Beta units, pre-production clinical units, and the pilot program. When the R&D team considers these factors and performs in-process testing, it can significantly improve product quality and reduce the overall cost of manufacturing.

Using DFMA 

The goal of DFMA is simple: to transfer product design into viable, robust production methods. To succeed, the team must establish and maintain procedures that ensure the device design translates into production specifications, including final test acceptance. The transfer should negate and/or identify remaining risks such as single-sourcing, long lead items, build timelines, and line/tooling capacity.

A Design Ready for Transfer:

  • Can be built reliably using known and proven manufacturing and assembly processes
  • Includes supporting cell/line qualifications through manufacturing validations such as Operational Qualification (OQ) and Performance Qualification (PQ)
  • Specifies and documents any inspection aids, assembly fixtures, and custom tools required for manufacture
  • Confirms completed agency testing and production target hardware meets regulatory requirements such as FDA, UL, and CE
  • Includes a complete product Bill of Material (BOM) that has been fully costed up to the customer Stock Keeping Unit (SKU) level
  • Includes packaging, labeling, and Instructions for Use (IFU)

At Sunrise Labs, we see Design Transfer as an integral process beginning early in the life of a product with many crucial steps for success. Communication between key stakeholders early and often is critical to turn innovative ideas into commercial medical devices.

Read more at sunriselabs.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Censis now reads da Vinci 2D codes to count arm uses

Censis now reads da Vinci 2D codes to count arm uses

Censis Technologies told CtUC 2026 attendees that CensiTrac has read the 2D matrix code on da Vinci arms since April, so robotic arms carry use counts without a second mark. The session built a business case for CensiTrac Advanced around marked assembly, clinic inventory ownership and par levels, with a 2021 BMJ Quality & Safety study putting missing instruments at 17.6% of assembly defects.

  • 01CensiTrac has counted da Vinci arm uses from the code that already comes on each arm since April, with no laser or etch added.
  • 02Hospitals told Censis they want clinic inventory tracking mainly to prove sterile processing did not lose the instruments.
  • 03Missing instruments were 17.6% of assembly tray defects at a 700-bed hospital in a 2021 BMJ Quality & Safety study, a problem the presenter tied to marked assembly.

Nov 5, 2026

AdvaMed digital health board approves data access best practices

AdvaMed digital health board approves data access best practices

AdvaMed's Digital Health Tech board approved voluntary Data Access Principles & Best Practices, announced October 28, setting four principles for how medtech companies and U.S. health systems share data.

  • 01The framework covers data vendors need to implement, monitor and improve technology, with expectations for transparency, stewardship and de-identification.
  • 02Watch for the first RFPs, security questionnaires or data use agreements that cite the principles by name; a voluntary document gains weight only when buyers adopt it.

Nov 5, 2026

Nearly 500 hospitals track shortage-affected segments via RFID

Nearly 500 hospitals track shortage-affected segments via RFID

According to Bluesight, nearly 500 hospitals track almost 4,000 shortage-affected medication segments in their RFID systems. Checks of dispensing cabinets have been missing that RFID-tracked supply. Gilman argues that bringing RFID data in next to cabinet data gives more complete usage rates and days-on-hand calculations, though the gain could depend on whether systems connect at the transaction level.

  • 01Gilman argues cabinet-only counts can miss RFID stock, fueling false urgency and emergency purchases, and can skew both stock-on-hand and usage-rate inputs in days-on-hand math.
  • 02RFID is no longer limited to kit and tray management: nearly 500 hospitals already track almost 4,000 shortage-affected medication segments in their RFID systems.
  • 03For operators weighing a merged feed, the key question could be whether RFID usage flows into the days-on-hand calculation at the transaction level or sits beside cabinet data as a static count.

Nov 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512